News & Updates

Show Multimedia Only

Which NSAID is most effective for osteoarthritis?

19 Oct 2021 by

The most effective nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and function in patients with osteoarthritis (OA) are etoricoxib 60 mg/day and diclofenac 150 mg/day, suggests a study. However, these medications may not be suitable for those with comorbidities or for long-term use due to the slight increase in the risk of adverse events.

19 Oct 2021

DOACs on par with LMWH at preventing VTE in cancer patients

19 Oct 2021

Cancer patients receiving either low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) show comparable frequency of venous thromboembolism (VTE), reports a recent study.

19 Oct 2021

Cochlear implants better than hearing aids, bone conduction device in single-sided deafness

19 Oct 2021 by

Cochlear implants (CI) outperform contralateral routing of sound hearing aids (CROS) and bone conduction devices (BCD) for improving sound perception in individuals with single-sided deafness (SSD), according to a recent study.

19 Oct 2021

Sarcopaenia in surgical ICU predicts poor functional outcomes after discharge

19 Oct 2021

Surgical intensive care unit (SICU) patients who develop sarcopaenia are more likely to experience poor functional outcomes after discharge, a recent Thailand study has found.

19 Oct 2021

Marine omega-3 supplementation may promote atrial fibrillation

19 Oct 2021

Supplementation with marine omega-3 fatty acids appears to contribute to an increased risk of atrial fibrillation (AF), especially at higher doses, according to the results of a meta-analysis.

19 Oct 2021

Tezepelumab improves lung function in severe asthma

19 Oct 2021

In the treatment of patients with severe, uncontrolled asthma, use of tezepelumab appears to produce rapid and sustained improvements in lung function, as reported in a study.

19 Oct 2021

Drinking tea may help preserve bone mineral density during menopause

18 Oct 2021

Women who began drinking tea before entering menopause seem to have better bone mineral density (BMD) than those who started drinking during and after menopause, a recent study has found.

18 Oct 2021

Ozanimod effective as induction, maintenance therapy for ulcerative colitis

18 Oct 2021 by

A once-daily oral formulation of ozanimod, a selective sphingosine-1-phosphate (S1P) receptor modulator, outdid placebo as induction and maintenance therapy for moderate-to-severe* active ulcerative colitis (UC), findings from the phase III True North study have shown.

18 Oct 2021